CSIMarket Company Name, Ticker, Customers, else..
 
Cosciens Biopharma Inc   (CSCI)
 
Price: $2.7200 $2.72 %
Day's High: $2.72 Week Perf: 45.45 %
Day's Low: $ 2.72 30 Day Perf: 39.49 %
Volume (M): 0 52 Wk High: $ 3.19
Volume (M$): $ 0 52 Wk Avg: $1.79
Open: $2.72 52 Wk Low: $0.79



 Market Capitalization (Millions $) 9
 Shares Outstanding (Millions) 3
 Employees 28
 Revenues (TTM) (Millions $) 8
 Net Income (TTM) (Millions $) -10
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


The company commercializes products based on its PGX Technology. It utilizes distribution partners, contract manufacturers, and sources high-quality ingredients and raw materials to manufacture and supply its products. The company encounters risks associated with market acceptance, competition, financing, regulatory compliance, intellectual property, and operational challenges.


   Company Address: c/o Borden Ladner Gervais, LLP Toronto 0 ON
   Company Phone Number: 900-3223   Stock Exchange / Ticker: CSCI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CING   -8.98%    
DMAC   -1.99%    
INBP      0% 
IRWD        2.91% 
PHAT        10.51% 
PTPI   -10%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.15
Price to Sales (Expected) -
Price to Book 2.24
PEG (TTM) -

Financial Strength Current
Quick Ratio 2.02
Working Capital Ratio 2.68
Leverage Ratio (MRQ) 4.58
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -3.27 $
Revenues (TTM) 2.37 $
Cash Flow (TTM) -
Cash 2.31 $
Book Value 1.21 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 267,786
Net Income per Employee (TTM) -369,929
Receivable Turnover Ratio (TTM) 27.74
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.29

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -604.81 %
Net Margin (MRQ) -123.61 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Cosciens Biopharma Inc's Segments
United states    61.4 % of total Revenue
Germany    31.72 % of total Revenue
United kingdom    6.09 % of total Revenue
Other    0.79 % of total Revenue
Active ingredients    93.85 % of total Revenue
Active ingredients United states    61.4 % of total Revenue
Active ingredients Germany    31.72 % of total Revenue
Active ingredients Other    0.73 % of total Revenue
Biopharmaceutical    6.15 % of total Revenue
Biopharmaceutical United kingdom    6.09 % of total Revenue
Biopharmaceutical Other    0.05 % of total Revenue
Single customer    84.05 % of total Revenue
Active ingredient    93.85 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.